anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
INTRODUCTION: Non-steroidal anti-inflammatory drugs (NSAIDs) are currently the most widely used anti-inflammatory medications, but their long-term use can cause damage to the gastrointestinal tract(GIT). One of the risk factors for GIT injury is exposure to a high-altitude hypoxic environment, which can lead to damage to the intestinal mucosal barrier. Taking NSAIDs in a high-altitude hypoxic environment can exacerbate GIT injury and impact gut microbiota. The aim of this study is to investigate the mechanisms by which resveratrol (RSV) intervention alleviates NSAID-induced intestinal injury in a high-altitude hypoxic environment, as well as its role in regulating gut microbiota.
METHODS: Aspirin was administered orally to rats to construct a rat model of intestinal injury induced by NSAIDs. Following the induction of intestinal injury, rats were administered RSV by gavage, and the expression levels of TLR4, NF-κB,IκB as well as Zonula Occludens-1 (ZO-1) and Occludin proteins in the different treatment groups were assessed via Western blot. Furthermore, the expression of the inflammatory factors IL-10, IL-1β, and TNF-α was evaluated using Elisa.16sRNA sequencing was employed to investigate alterations in the gut microbiota.
RESULTS: The HCk group showed elevated expression of TLR4/NF-κB/IκB pathway proteins, increased expression of pro-inflammatory factors IL-1β and TNF-α, decreased expression of the anti-inflammatory factor IL-10, and expression of intestinal mucosal barrier proteins ZO-1 and Occludin. The administration of NSAIDs drugs in the plateau hypoxic environment exacerbates intestinal inflammation and damage to the intestinal mucosal barrier. After treatment with RSV intervention, the expression of TLR4/NF-κB/IκB signaling pathway proteins would be reduced, thereby lowering the expression of inflammatory factors in the HAsp group. The results of HE staining directly show the damage to the intestines and the repair of intestinal mucosa after RSV intervention. 16sRNA sequencing results show significant differences (P<0.05) in Ruminococcus, Facklamia, Parasutterella, Jeotgalicoccus, Coprococcus, and Psychrobacter between the HCk group and the Ck group. Compared to the HCk group, the HAsp group shows significant differences (P<0.05) in Facklamia, Jeotgalicoccus, Roseburia, Psychrobacter, and Alloprevotella. After RSV intervention, Clostridium_sensu_stricto bacteria significantly increase compared to the HAsp group.
CONCLUSION: Resveratrol can attenuate intestinal damage caused by the administration of NSAIDs at high altitude in hypoxic environments by modulating the TLR4/NF-κB/IκB signaling pathway and gut microbiota composition.
Neisseria meningitidis causes meningitis and severe infections of the blood stream. The incidence of serogroup B meningococcal disease however is too low to conduct a randomized, controlled trial to determine the actual efficacy of the new serogroup B vaccines. Instead vaccine efficacy was inferred from serum bactericidal antibody responses using four test strains. However, because of strain variability of FHbp amino acid sequence (there are more than 800 sequence variants described) and strain variability of FHbp expression, bactericidal data on only four strains are unlikely to be sufficient to predict the actual strain coverage by the vaccine. There also are gaps in knowledge about the underlying mechanisms by which human antibodies to FHbp elicit complement mediated bactericidal activity. For example, binding of FH to FHbp is specific for human FH. Therefore in vaccinated humans the vaccine antigen is expected to form a complex with FH right after immunization. The investigators' hypothesis is that binding of human FH to the vaccine antigen skews the antibody repertoire to FHbp epitopes located outside of the FH combining site. The resulting antibodies would be expected not to inhibit binding of FH to the bacteria. This hypothesis will be investigated in Trumenba-immunized humans as part of studies in Aim 1 (and in future studies of recombinant human anti-FHbp Fabs that will be enabled by obtaining DNA from individual B cells, described in Aim 2).
Hand hygiene is the most important strategy to prevent the transmission of microorganisms between patients, healthcare personnel and the healthcare environment. This study was conducted to determine the effect of hand hygiene training given to home patient care students with different methods on their hand hygiene beliefs, practices and skills. This study was a randomized controlled trial. The population of the study consisted of 123 students. After the removals, the study was completed with 75 students in the video (n=25), paint (n=25) and control (n=25) groups. In the intervention of the study, lecture, discussion, question and answer, demonstration, coloring and video methods were used.
A computer-implemented method for determining a score indicative of mindfulness of a user is provided. The method includes obtaining heart rate variability data of the user during a guided breathing exercise in which the user inhales and exhales to mimic a respiration rate associated with mindfulness. The method includes filtering the heart rate variability data to generate filtered heart rate variability. The method includes determining a first standard deviation of interbeat intervals indicative of respiratory sinus arrythmia and included in a first segment of the filtered heart rate variability data that spans a discrete interval of time. The method includes determining a second standard deviation of all interbeat intervals included in the first segment of the filtered heart rate variability data. The method includes determining a score indicative of mindfulness of the user based on the first standard deviation and the second standard deviation.
BACKGROUND: Sotos syndrome (SS) is a rare disorder characterized by overgrowth, distinctive facial features, and intellectual disability that is primarily caused by NSD1 pathogenic variants or 5q35 microdeletions.
METHODS: We retrospectively analyzed the clinical characteristics and 339 anthropometric measurements over an average of 4.3 years of follow-up in 57 Korean children with SS. Sex-specific percentile curves for height, weight, and head circumference were developed using a generalized additive model that included factors such as location, scale, and shape.
RESULTS: Males with SS demonstrated higher height before the age of 12.0, greater weight before 10.0, and larger head circumference before 15.5 compared to age- and sex-matched controls. Females with SS displayed higher height before 17.0, greater weight before 10.5, and larger head circumference before 12.0 compared to controls. Bone age was advanced compared to chronological age in 40% of males and 8% of females at their last visit. The predicted and target adult heights were not significantly different between groups. In subgroup analysis, the intragenic variant group (n = 48) showed a higher mean standard deviation score of height and weight in males, and head circumference in females compared to the microdeletion group (n = 9).
CONCLUSIONS: Korean children with genetically confirmed SS exhibited overgrowth in height, weight, and head circumference. Overgrowth phenotypes were more prominent in patients with NSD1 intragenic variants than in those with microdeletions. This is the first study to provide reference data on the growth of Korean children with SS.
Each treatment cycle consists of once daily oral dosing of 4000 mg placebos, every day throughout each 12 week (84 day) cycle. Patients may continue to receive additional cycles of placebo and will be followed every three months with standard visits with their physician until completion of 48 weeks of study treatment, disease progression, or until they wish to discontinue the drug.
The invention discloses a formula for treating alopecia areata. The formula consists of the following raw materials in parts by weight: 60g of sesame flower, 60g of cockscomb flower, 1.5g of camphor and 500g of distilled spirit. A preparation method of the formula comprises the following steps: tearing the sesame flower and cockscomb flower, then soaking into the distilled spirit, sealing, filtering after sealing for 15 days, and then adding camphor into a medicated wine to dissolve for later use. An application method of the formula comprises the following steps: dipping the medicated wine by using medicinal cotton, smearing the medicated wine on a hair loss area, applying the medicated wine for 3-4 times per day, and continuously applying for 30 days. The formula disclosed by the invention has the advantages that the formula can be used for fundamentally treating alopecia areata. Alopecia areata can be treated by virtue of the following steps: dipping a medicament liquid by using the medicinal cotton to wipe an affected part for 3-4 times per day, and continuously applying the medicament liquid for 30 days. The total effective rate of the formula can reach 98%.
Provided is dexlansoprazole propylene glycolate hydrate. Polymorphic forms thereof are also provided. The dexlansoprazole propylene glycolate hydrate maybe such that the propylene glycol component is present in approximately equal proportions of (R) absolute configuration and (S) absolute configuration, or present in predominantly (R) absolute configuration, or predominantly (S) absolute configuration. Salts of dexlansoprazole are also provided. In particular, crystalline dexlansoprazole isopropylammonium salt and crystalline MTBE solvate of dexlansoprazole t-butylammonium salt are provided. Pharmaceutical formulations comprising dexlansoprazole propylene glycolate hydrate are also provided. Furthermore, processes for preparation of dexlansoprazole propylene glycolate hydrate are provided.
One of the most devastating consequences of cervical spinal cord injury (SCI) is damage to the phrenic motor network, controlling the diaphragm (primary muscle of breathing). Subsequent diaphragm paralysis or paresis results in life-threatening impairments in breathing and can necessitate a need for ventilator assistance. Respiratory and cardiovascular complications are the most common causes of death in the first year post-injury (51% combined). Thus, there is an urgent need to develop strategies for improving function for people with acute and chronic spinal cord injury. Currently, treatments for respiratory dysfunction in spinal cord injury patients are limited to mechanical devices or nerve pacing. Moreover, the proposed plan of studying respiratory muscle training in spinal cord injury patients is novel. However, it is based on animal and human studies that have shown with validity that respiratory muscle training using mild intermittent hypoxia improves respiratory function following SCI. However, the effect of intermittent hypoxia has shown to be dependent on the level of alveolar CO2 and may pose undesirable cardiovascular effects. Previous studies showed that respiratory recovery following SCI manifests by a delayed and partial restorative spontaneous plasticity. The current research project and future anticipated studies would set the base for developing innovative therapies that can stimulate respiratory plasticity hence recovery for this prevalent disorder.

The proposed pilot/feasibility study will test the effect of daily acute intermittent hypercapnia (dAIHc) in individuals with SCI. The objectives of this study are to (1) determine recruitment rates and test the feasibility of recruitment, (2) calculate withdrawal and dropout rates, (3) test the feasibility and tolerability and acceptability of the proposed intervention in an SCI population, (4) develop and refine a new respiratory training intervention using dAIHc paradigm (5) derive effect size estimates for clinical endpoints and their associated variability at the end of treatment to calculate an appropriate sample size for an adequately powered clinical trial. Compared to sham therapy, the central hypothesis is that the daily respiratory muscle training (dAIHc) approach is acceptable and feasible in patients with SCI and will strengthen respiratory muscles and reduce the severity of sleep-disordered breathing (SDB), and will improve daytime symptoms.

This study is highly innovative and the first of its kind in patients with SCI, as it seeks first to use a new set of rehabilitative exercises to improve ventilation and respiratory muscles strength; secondly, it aims to use controlled randomized design; finally, it will determine the role of respiratory muscle exercises in reducing the severity of sleep symptoms and daytime function in SCI. Each aim is independently testable and does not depend on the result of the other aims. The findings will likely apply to a broad range of other neuromuscular diseases (such as Multiple Sclerosis and Stroke). The team of this pilot project has the resources and IRB approval necessary to execute the project.
New diabetes can develop after transplant and may affect a transplanted kidney's health and a recipient's overall health. Currently, patients who are pre-diabetic are encouraged to exercise and lose weight. Researchers are planning to test whether an addition of this medication will lead to better results and more effectively prevent diabetes in patients who already have high blood sugars.

Exenatide SR is medication given by weekly injection. It increases insulin release in response to a meal and slows digestion. This medicine is already in use and approved by the US Food and Drug Administration (FDA) in patients with diabetes. However, it has not been approved for this indication; the FDA has allowed the use of this drug in this research study.
MLC601 (NeuroAideTM) is a TCM which is used extensively in China to improve recovery after stroke. It combines several herbal and animal components.
The invention relates to a method for preparing a medicament used for treating hepatic fibrosis. According to the method, 180 grams of ipomoea pes-caprae, 160 grams of selaginella sinensis, 150 grams of liparis nervosa, 160 grams of pentapetes phoenicea, 150 grams of Elatostema oblohgifolium Fu, 130 grams of ottelia alismoides, 120 grams of Saururus chinensis, 120 grams of Fraxinus malacophylla, 110 grams of tabula rasa radix ranunculus ternate, 110 grams of orchis, 100 grams of tempeh grass, 100 grams of Sapium sebiferum var.laxicarpum Hu, 80 grams of Hibiscus taiwanensis, 80 grams of flatstem rockvine stem and root, 60 grams of Desmodium heterocarpum and 50 grams of licorice are added in 15000mL of water and the obtained mixture is heated for 5 hours in the reflux condition. After that, the obtained product is filtered to obtain a filter cake 1 and a filtrate 1. 10000mL of water is added into the filter cake 1 and the obtained mixture is heated for 3 hours in the reflux condition. After that, the obtained product is filtered to obtain a filter cake 2 and a filtrate 2. 8000 mL of water is added into the filter cake 2 and the obtained mixture is heated for 1 hour in the reflux condition. After that, the obtained product is filtered to obtain a filter cake 3 and a filtrate 3. The filtrate 1, the filtrate 2 and the filtrate 3 are mixed and concentrated to 10000mL to obtain the medicament.
PURPOSE:To obtain a powdery preparation produced by forming a syrup containing galactooligosaccharide with zeolite in the form of pharmaceutical preparation, producible at a low cost and having easy handleability in the compounding of the preparation to a feed. CONSTITUTION:The objective preparation is composed of (A) a syrup containing galactooligosaccharide and (B) a zeolite (preferably mordenite-type zeolite). The preparation is preferably produced by kneading and granulating the components A and B with a high-speed agitation mixing granulator, a kneader, etc., and, as necessary, subjecting the obtained granules to coarse crushing, sieving and drying. The component A preferably has a solid concentration of >=75% in the syrup and a galactooligosaccharide concentration of >=50% in the solid component. The galactooligosaccharide is e.g. 6-galactosyl lactose produced by treating lactose with beta-galactosidase.
The most common complaint in palliative care patients is pain. Therefore, the quality of palliative care is demonstrated by the good management of patients' pain and suffering. In the treatment of pain, pharmacological and non-pharmacological treatments should be used together. As a result of the relaxation of the muscles with massage, which is one of the non-pharmacological treatments, the pain is relieved and reduced. Again, massage increases the release of endorphins and reduces the feeling of pain. Another common complaint in palliative care patients is insomnia. Sleep quality is also linked to pain. Low sleep quality causes a decrease in tolerance to pain, more drugs are used to relieve pain, and a negative cycle is formed by affecting sleep quality. Massage is one of the oldest treatment methods used to relieve many ailments. Florence Nightingale described massage in her Notes on Nursing published in 1859 and provided its use in the field of nursing.

This study was planned to evaluate the effect of back massage applied to palliative care patients on sleep quality and pain.

The study was planned as a randomized controlled experimental study between November 2021 and June 2022. Patients hospitalized in the Palliative Care Service of Bilecik Training and Research Hospital, the sample will be 52 patients, 26 patients in each group, with a 95% CI 90% power, as a result of the calculation made using the G\*Power 3.1.9.7 program. Written consent will be obtained from the patients who agree to participate in the study and the "Patient Identification Form" will be filled. Back massage will be applied to the experimental group for 10 minutes every day for 7 days. Pittsburgh Sleep Quality Index, McGill Pain Scale Short Form will be administered after each massage and scores will be recorded for 7 days. Scales and massage will be applied to the patients before the administration of the pharmacological agent, which is among the routine treatment and care practices in the clinic. The control group will not be interfered with, and the routine treatment and care practices in the clinic will continue. Pittsburgh Sleep Quality Index, McGill Pain Scale Short will be applied to the control group simultaneously with the experimental group and scores will be recorded for 7 days. The obtained data will be evaluated using appropriate statistical methods.

As a result of the research, it is thought that the questions of whether there is a significant difference in sleep quality and pain scale between the patient group who received back massage in palliative care and the patient group who did not receive it will be answered.
A novel B.t. toxin gene encoding a protein toxic to coleopteran insects has been cloned from a novel coleopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
Participants who have received treatment for early stage breast cancer and who experience insomnia, assessed as difficulty sleeping over the last week, yes or no, per patient report. Participants will complete baseline symptom questionnaires, then complete an internet-based cognitive behavioral therapy program (PROSPECT) for 8 weeks, then repeat questionnaires.
The invention relates to a bionic engineering mediated immune cell active targeting in-vivo self-running nanoscale gene delivery system fusing a biomass membrane, and a preparation method and application thereof. The invention comprises 1) a synthesis method for synthesizing macrophage membrane hybridization lipid nanometer RNA vaccine 2) a method for extracting macrophage source non-nuclear cell membrane vesicle. 3) Based on hybrid lipid vesicles and ionizable amino cationic lipids. The invention has the advantages that: 1) The hybrid membrane system of the prepared lipid nanoparticle can remarkably enhance the escape capacity of the immune system. 2) The ionizable cationic head group can reduce cytotoxicity, improve cell viability, and the cell viability is 85% -95%. 3) The particle size of the prepared lipid nanoparticle is 100-200nm, the cell transfection efficiency is 60-80%, and the transfection efficiency is high.
Giant cell tumor of the bone (GCTB) is a rare primary bone neoplasm, representing about 5% of all primary bone tumors. Most GCTBs are found in the epiphysis of long bones, with only 2% of GCTBs involving the skull. In recent years, the receptor activator of nuclear factor Kappa ligand monoclonal antibody denosumab has been demonstrated as a promising therapeutic option for GCTB; however, this is an evolving field. We present a case of a 57-year-old female with a rare GCTB in the right orbit and sinuses, originally thought to be an aneurysmal bone cyst. Her symptoms included proptosis, intermittent blurry vision, sinus congestion, and frontal headaches. After excision, the tumor recurred within 18 months. Upon repeat excision, a diagnosis of GCTB was made. The patient started denosumab therapy and had no tumor growth over the ensuing 2 years, with stability of symptoms and clinical signs on follow-up.
Egg storage is a common practice in commercial hatcheries, but prolonged storage can negatively impact hatchability, causing a significant problem for the poultry industry. Repeated pre-incubation could mitigate the decline depending on the age of the parent stock. The study investigated the interactions between parent stock age (30, 45, and 58 weeks) and repeated pre-incubation on the hatchability and embryo development of 15-day stored eggs from Ross 308 parent stock. Three different pre-incubation durations were employed during storage: no pre-incubation and twice at the 5th and 10th days of egg storage for either 4 or 8 h. For each parent stock age, 3 600 eggs collected on the same day from the same parent stock were used for hatchability assessment. The duration of pre-incubation was determined as the eggshell temperature increased from 28 °C to a maximum of 35 °C and then cooled to 28 °C; the persistency at 35 °C was either 1 or 4 h for the total pre-incubation period. The hatchability of both set and fertile eggs and early, middle, and late embryonic mortality depended on the parent stock's age (P < 0.001). Pre-incubation alone did not have any impact on hatchability. Conversely, a significant interaction was observed between parent stock age and pre-incubation duration on the hatchability of fertile eggs (P = 0.001). At 30 weeks of parent stock age, both durations of pre-incubation positively influenced the hatchability. At 45 weeks of parent stock age, pre-incubation length had no effect on hatchability. At 58 weeks of parent stock age, a longer pre-incubation period, 2 × 8 h, was associated with decreased hatchability. Early embryonic mortality was not influenced by pre-incubation. However, a significant interaction was observed (P = 0.003). At 30 weeks of parent stock age, both short and long lengths of pre-incubation were associated with a decrease in early embryonic mortality. However, at 45 and 58 weeks, pre-incubation did not significantly affect early embryonic mortality. Additionally, longer pre-incubation periods significantly increased middle mortality compared to untreated eggs (P = 0.035). The median of embryo development for untreated eggs was the same across all ages (stage 10). In the older parent stock (45 and 58 weeks), repeated pre-incubation increased variability in embryo development, while in the younger parent stock, repeated pre-incubation decreased variability in embryo development. In conclusion, the duration and the frequency of pre-incubation should be specified based on the age of the parent stock.